Enovis Income from Continuous Operations 2010-2025 | ENOV
Enovis income from continuous operations from 2010 to 2025. Income from continuous operations can be defined as a company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change
| Enovis Annual Income from Continuous Operations (Millions of US $) |
|
|---|---|
| 2024 | $-827 |
| 2023 | $-54 |
| 2022 | $-38 |
| 2021 | $-102 |
| 2020 | $-74 |
| 2019 | $19 |
| 2018 | $122 |
| 2017 | $46 |
| 2016 | $155 |
| 2015 | $177 |
| 2014 | $420 |
| 2013 | $209 |
| 2012 | $-42 |
| 2011 | $5 |
| 2010 | $16 |
| 2009 | $24 |
| Enovis Quarterly Income from Continuous Operations (Millions of US $) |
|
|---|---|
| 2025-06-30 | $-36 |
| 2025-03-31 | $-56 |
| 2024-12-31 | $-704 |
| 2024-09-30 | $-34 |
| 2024-06-30 | $-18 |
| 2024-03-31 | $-72 |
| 2023-12-31 | $3 |
| 2023-09-30 | $-19 |
| 2023-06-30 | $-15 |
| 2023-03-31 | $-23 |
| 2022-12-31 | $-55 |
| 2022-09-30 | $-66 |
| 2022-06-30 | $121 |
| 2022-03-31 | $-38 |
| 2021-12-31 | $-74 |
| 2021-09-30 | $-14 |
| 2021-06-30 | $-42 |
| 2021-03-31 | $28 |
| 2020-12-31 | $-97 |
| 2020-09-30 | $17 |
| 2020-06-30 | $-3 |
| 2020-03-31 | $9 |
| 2019-12-31 | $34 |
| 2019-09-30 | $4 |
| 2019-06-30 | $2 |
| 2019-03-31 | $-22 |
| 2018-12-31 | $25 |
| 2018-09-30 | $17 |
| 2018-06-30 | $48 |
| 2018-03-31 | $32 |
| 2017-12-31 | $-84 |
| 2017-09-30 | $50 |
| 2017-06-30 | $42 |
| 2017-03-31 | $38 |
| 2016-12-31 | $44 |
| 2016-09-30 | $41 |
| 2016-06-30 | $44 |
| 2016-03-31 | $26 |
| 2015-12-31 | $38 |
| 2015-09-30 | $24 |
| 2015-06-30 | $59 |
| 2015-03-31 | $56 |
| 2014-12-31 | $86 |
| 2014-09-30 | $81 |
| 2014-06-30 | $198 |
| 2014-03-31 | $55 |
| 2013-12-31 | $44 |
| 2013-09-30 | $65 |
| 2013-06-30 | $67 |
| 2013-03-31 | $32 |
| 2012-12-31 | $25 |
| 2012-09-30 | $14 |
| 2012-06-30 | $19 |
| 2012-03-31 | $-100 |
| 2011-12-31 | $-16 |
| 2011-09-30 | $4 |
| 2011-06-30 | $10 |
| 2011-03-31 | $7 |
| 2010-12-31 | $9 |
| 2010-09-30 | $6 |
| 2010-06-30 | $2 |
| 2010-03-31 | $0 |
| 2009-12-31 | $7 |
| 2009-09-30 | $6 |
| 2009-06-30 | $4 |
| 2009-03-31 | $7 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $1.771B | $2.108B |
| Enovis Corporation is a medical technology company. Its range of products, services and integrated technologies fuel active lifestyles in orthopedics and beyond. Enovis Corporation, formerly known as Colfax Corporation, is based in Wilmington, DE. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $46.602B | 59.29 |
| Tempus AI (TEM) | United States | $13.186B | 0.00 |
| Doximity (DOCS) | United States | $12.437B | 55.33 |
| Hims & Hers Health (HIMS) | United States | $9.717B | 79.61 |
| IRhythm Technologies (IRTC) | United States | $5.323B | 0.00 |
| Hinge Health (HNGE) | United States | $4.319B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $2.748B | 40.40 |
| Privia Health (PRVA) | United States | $2.626B | 194.54 |
| Heartflow (HTFL) | $2.422B | 0.00 | |
| Phreesia (PHR) | United States | $1.808B | 0.00 |
| 10x Genomics (TXG) | United States | $1.752B | 0.00 |
| Omnicell (OMCL) | United States | $1.520B | 29.28 |
| Schrodinger (SDGR) | United States | $1.438B | 0.00 |
| Azenta (AZTA) | United States | $1.410B | 61.52 |
| Clover Health Investments (CLOV) | United States | $1.356B | 0.00 |
| Claritev (CTEV) | United States | $1.180B | 0.00 |
| Evolent Health (EVH) | United States | $1.140B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.659B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.570B | 0.00 |
| Veradigm (MDRX) | United States | $0.525B | 0.00 |
| Standard BioTools (LAB) | United States | $0.474B | 0.00 |
| Talkspace (TALK) | United States | $0.445B | 132.75 |
| Butterfly Network (BFLY) | United States | $0.390B | 0.00 |
| Carlsmed (CARL) | United States | $0.380B | 0.00 |
| TruBridge (TBRG) | United States | $0.298B | 52.29 |
| Outset Medical (OM) | United States | $0.244B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.235B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.233B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.220B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.194B | 0.00 |
| CapsoVision (CV) | United States | $0.187B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.167B | 0.00 |
| CareCloud (CCLD) | United States | $0.135B | 6.12 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.127B | 0.00 |
| American Well (AMWL) | United States | $0.113B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.099B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.071B | 0.00 |
| Pulmonx (LUNG) | United States | $0.068B | 0.00 |
| 111 (YI) | China | $0.061B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.053B | 0.00 |
| HeartBeam (BEAT) | United States | $0.038B | 0.00 |
| Zhongchao (ZCMD) | China | $0.026B | 0.00 |
| Precipio (PRPO) | United States | $0.023B | 0.00 |
| PROFUSA (PFSA) | United States | $0.016B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.016B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.012B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| HeartSciences (HSCS) | United States | $0.008B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.007B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.006B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.005B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |